论文部分内容阅读
通过对140例原发性非IgA系膜增生性肾小球肾炎(non—IgAMsPGN)患者疗效的回顾性分析,观察中西医结合治疗对该类患者临床类型、病理损害程度、中医证型与疗效的相关性。结果显示,临床缓解91例(65％),显效23例(16.4％),好转15例(10.7％),无效11例(7.9％),表明原发性non—IgAMsPGN的中西医结合治疗应注重临床与病理的检测,其疗效与病理损害的严重性有关;注重辨病与辨证相结合,不同中医证型的疗效相似(P>0.05)。
Through retrospective analysis of 140 cases of non-IgA mesangial proliferative glomerulonephritis (non-IgAMsPGN) patients, we observed the clinical type, pathological damage, TCM syndrome type and curative effect Relevance. The results showed that clinical remission in 91 cases (65%), markedly effective in 23 cases (16.4%), improved in 15 cases (10.7%) and ineffective in 11 cases (7.9%), indicating that the primary non-IgAMsPGN Integrative Medicine should pay attention to Clinical and pathological detection, the curative effect and the severity of pathological damage related; pay attention to disease differentiation and syndrome combined with different TCM syndromes (P> 0.05).